About UCB
Headquartered in Brussels, Belgium cb , UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions designed to improve the lives of patients suffering from disorders of the immune system or serious diseases of the central nervous system. UCB has around 9,000 employees in around 40 countries and generated revenues of EUR 5.3 billion in 2023. UCB is listed on Euronext Brussels ticker symbol: UCB.
XtalPi Holdings Limited " XtalPi Holdings Limited" , stock russia telegram data abbreviation: XtalPi Holdings -P , XTALPI-P , stock code: 2228K was founded in 2015 by three physicists from the Massachusetts Institute of Technology . It is an innovative R&D platform based on quantum physics, enabled by artificial intelligence and driven by robots. The company uses a combination of quantum physics-based first-principles computing, artificial intelligence, high-performance cloud computing, and scalable and standardized robotic automation to provide drug and material science R&D solutions and services to global and domestic companies in industries such as pharmaceuticals and material sciences including agricultural technology, energy and new chemicals, and cosmetics.
About Ailux Biologics
Ailux Biologics is the macromolecule drug discovery innovation department of XTALPI XTALPI -P , stock code: 2228K . With a team of approximately 100 experts, it has established a first-class macromolecule drug discovery laboratory, a proprietary database AtlaX™ built specifically for AI , and three major AI platforms - including the structural modeling platform XtalFold™ , the generative protein language model XenProT™, and the macromolecule drug property prediction platform Xentient™ . Ailux Biologics works with large pharmaceutical and biotech companies to accelerate their partners’ large molecule drug discovery with its AI- driven, wet-lab validated solutions.